Maximum quantity allowed is 999
Please select the quantity
CAS RN: 121268-17-5 | Product Number: A2456
Alendronate Sodium Trihydrate
×
![]()
×
Purity: >97.0%(T)
Synonyms:
- Alendronic Acid Monosodium Salt Trihydrate
- (4-Amino-1-hydroxy-1-phosphonobutyl)phosphonic Acid Monosodium Salt Trihydrate
- Monosodium (4-Amino-1-hydroxy-1-phosphonobutyl)phosphonate Trihydrate
Product Documents:
| Size | Unit Price | Hyderabad | Japan* | Quantity |
|---|---|---|---|---|
| 5G |
₹8,000.00
|
1 | ≥100 |
|
| 25G |
₹13,200.00
|
3 | ≥40 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | A2456 |
| Purity / Analysis Method | >97.0%(T) |
| Molecular Formula / Molecular Weight | C__4H__1__2NNaO__7P__2·3H__2O = 325.13 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Frozen (<0°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 121268-17-5 |
| Related CAS RN | 66376-36-1&129318-43-0 |
| Reaxys Registry Number | 6947932 |
| PubChem Substance ID | 135727181 |
| Merck Index (14) | 229 |
| MDL Number | MFCD01748233 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(Neutralization titration) | min. 97.0 % |
| Drying loss | 16.1 to 17.1 % |
Properties (reference)
| Solubility in water | Slightly soluble |
| Solubility (insoluble in) | Chloroform |
GHS
Related Laws:
| RTECS# | SZ6523666 |
Transport Information:
Application
Studies of Alendronate Biological Actions
References
- Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure
- Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
- Synthesis, characterization and biodistribution of bisphosphonates Sm-153 complexes: correlation with molecular modeling interaction studies
- Synthesis and Study of Alendronate Derivatives as Potential Prodrugs of Alendronate Sodium for the Treatment of Low Bone Density and Osteoporosis
Application
Bone Resorption Inhibitors
References
- 1)Anti-bone resorption
- a)J. E. Dunford, K. Thompson, F. P. Coxon, S. P. Luckman, F. M. Hahn, C. D. Poulter, F. H. Ebetino, M. J. Rogers., J. Pharmacol. Exp. Ther. 2001, 296, 235.
- b)E. Hiroi-Furuya, T. Kameda, K. Hiura, H. Mano, K. Miyazawa, Y. Nakamaru, M. Watanabe-Mano, N. Okuda, J. Shimada, Y. Yamamoto, Y. Hakeda, M. Kumegawa, Calcif. Tissue Int. 1999, 64, 219.
PubMed Literature
Articles/Brochures
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.